|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||15.35 - 16.14|
|52-week range||11.65 - 21.05|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||8.52|
|Forward dividend & yield||0.76 (4.54%)|
|Ex-dividend date||29 Apr 2020|
|1y target est||18.40|
Regeneron (REGN) beats on Q4 earnings and sales on solid performance of Dupixent, Eylea and incremental contribution from oncology drug, Libtayo.
Bayer (BAYRY) gets a boost as it wins approvals for a few candidates and enters into collaboration agreements.
Merck (MRK), Glaxo (GSK), AstraZeneca (AZN) and J&J (JNJ) announce FDA approvals.